KRAS and melanoma: Previous studies have shown that DNA in EVs not only covers the entire genome of parental cells, but also allows identical mutations from the cells they are derived from to be detected, including clinically relevant mutations such as KRAS mutations in pancreatic cancer or BRAF in melanoma [11,12,13,14,38].